These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A novel splice-site mutation in CHMP2B associated with frontotemporal dementia: The first report from China and literature review. Li C; Wen Y; Zhao M; Wang Y; Li P; Wang L; Wang S Mol Genet Genomic Med; 2023 Aug; 11(8):e2222. PubMed ID: 37272767 [TBL] [Abstract][Full Text] [Related]
11. CHMP2B mutations are not a cause of dementia in Dutch patients with familial and sporadic frontotemporal dementia. Rizzu P; van Mil SE; Anar B; Rosso SM; Donker Kaat L; Heutink P; van Swieten JC Am J Med Genet B Neuropsychiatr Genet; 2006 Dec; 141B(8):944-6. PubMed ID: 16941655 [TBL] [Abstract][Full Text] [Related]
12. Frontotemporal dementia linked to chromosome 3 (FTD-3)--current concepts and the detection of a previously unknown branch of the Danish FTD-3 family. Lindquist SG; Braedgaard H; Svenstrup K; Isaacs AM; Nielsen JE; Eur J Neurol; 2008 Jul; 15(7):667-70. PubMed ID: 18484988 [TBL] [Abstract][Full Text] [Related]
14. Absence of FUS-immunoreactive pathology in frontotemporal dementia linked to chromosome 3 (FTD-3) caused by mutation in the CHMP2B gene. Holm IE; Isaacs AM; Mackenzie IR Acta Neuropathol; 2009 Nov; 118(5):719-20. PubMed ID: 19844732 [No Abstract] [Full Text] [Related]
15. TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III. Jun MH; Han JH; Lee YK; Jang DJ; Kaang BK; Lee JA Mol Brain; 2015 Dec; 8():85. PubMed ID: 26651479 [TBL] [Abstract][Full Text] [Related]
16. Longitudinal transcriptomic analysis of altered pathways in a CHMP2B Waegaert R; Dirrig-Grosch S; Parisot F; Keime C; Henriques A; Loeffler JP; René F Neurobiol Dis; 2020 Mar; 136():104710. PubMed ID: 31837425 [TBL] [Abstract][Full Text] [Related]